• OPEN AN ACCOUNT
Indian Indices
Sensex
73,895.74 315.20
( 0.43%)
Global Indices
Nasdaq
51,839.66 468.68
(0.91%)
Dow Jones
7,763.25 38.12
(0.49%)
Hang Seng
66,308.10 794.11
(1.21%)
Nikkei 225
10,694.57 14.58
(0.14%)
Forex
USD-INR
95.73 0.08
(0.09%)
EUR-INR
109.20 -0.36
(-0.33%)
GBP-INR
127.12 -0.62
(-0.48%)
JPY-INR
0.61 0.00
(-0.28%)

EQUITY - MARKET SCREENER

Natco Pharma Ltd
Industry :  Pharmaceuticals - Indian - Bulk Drugs & Formln
BSE Code
ISIN Demat
Book Value()
524816
INE987B01026
477.507017
NSE Symbol
P/E(TTM)
Mar.Cap( Cr.)
NATCOPHARM
16.87
15046.12
EPS(TTM)
Face Value()
Div & Yield %
49.8
2
0.59
 

OM Infra gains on securing irrigation infrastructure works under Gosikhurd Project
Sep 23,2026

The said work order, awarded under the Gosikhurd Project, has been issued by the Office of the Executive Engineer, Ghodazari Canal Division, Nagbhid.

The contract encompasses the construction of a lift irrigation scheme (LIS) designed to feed the Ghodazari Tank from RD 17213 m of the Ghodazari Branch Canal, an integral component of the Gosikhurd Project in Maharashtra.

The total value of this contract is Rs 32.17 crore. The project has to be executed within a period of 12 months from the date of issuance.

OM Infra is a leading infrastructure development company specializing in engineering, procurement, and construction (EPC) projects for water management, engineering, and construction.

The company had reported a consolidated net profit of Rs 11.45 crore in the quarter ended June 2026 as against net loss of Rs 0.98 crore during the previous quarter ended June 2025. Revenue rose 19.20% to Rs 124.37 crore in Q1 FY27 over Q1 FY26.